Scripps Research is a biopharmaceutical and biotechnology startup founded in 1993. The company recently secured a substantial $67.00M grant investment on 18 May 2022 from the National Institute of Allergy and Infectious Diseases. This significant investment reflects the trust and interest of major players in the healthcare and biotech sector, positioning Scripps Research as a potential leader in developing innovative solutions for pertinent global health challenges.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Grant | $67.00M | 1 | National Institute of Allergy and Infectious Diseases | 18 May 2022 |
No recent news or press coverage available for Scripps Research.